# Survival of cancer patients from Gaza by the outcome of their first permit application, 2008 to 2017

Source: https://onco.cc/key-papers/paper-bouquet-gaza-cancer-permits-survival-plos-one-2021/  
OnCo record `paper-bouquet-gaza-cancer-permits-survival-plos-one-2021` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A study that WHO's 2023 report cites as WHO research matched 17,072 permit applications for 3,816 cancer patients from Gaza referred for chemotherapy or radiotherapy. For 2015 to 2017, death was more likely among those whose first application was not approved in time.

## Summary

Published as "Comparative survival of cancer patients requiring Israeli permits to exit the Gaza Strip for health care: A retrospective cohort study from 2008 to 2017". The authors matched permit applications from 1 January 2008 to 31 December 2017 with referral data and with mortality data to 30 June 2018, and compared survival by the first decision (approved against denied or delayed), separately for 2008 to 2014 and 2015 to 2017.

## Fields

- Kind: Key paper
- Last checked: 2026-11-16
- Journal: PLoS One
- Year: 2021
- DOI: 10.1371/journal.pone.0251058
- Authors: Bouquet B, Barone-Adesi F, Lafi M, Quanstrom K, Riccardi F, Doctor H, et al.
- Findings: 17,072 permit applications for 3,816 cancer patients referred for chemotherapy and/or radiotherapy were matched.; For first applications in 2015 to 2017, mortality was higher among patients whose application was unsuccessful: hazard ratio 1.45 (95% CI 1.19 to 1.78).; For first applications in 2008 to 2014, the abstract reports no significant difference in mortality risk between the two groups.; The abstract gives the approval rate for patient permits to exit Gaza as 94% in 2012 and 54% in 2017.
- What it means: A cohort study of mortality by the outcome of a first travel permit application, for people from Gaza referred for chemotherapy or radiotherapy elsewhere. It found a difference for 2015 to 2017 and none for 2008 to 2014. WHO's 2023 report on 2019 to 2021 cites it.
- Caveats: An observational cohort: it compares groups and cannot rule out other differences between them.; The data end in 2018. WHO's summary to 31 October 2026 describes a different route since October 2023, medical evacuation abroad.; OnCo read the abstract, not the full text.

## Sources

- PLoS One 2021: https://doi.org/10.1371/journal.pone.0251058
- PubMed: https://pubmed.ncbi.nlm.nih.gov/34077436/

## Connected records

- key papers: [Breast cancer in women in Gaza diagnosed in 2017 and 2018: stage, treatment and two-year survival](https://onco.cc/key-papers/paper-alwaheidi-breast-cancer-gaza-jco-go-2024/)
- institutions: [Palestinian Ministry of Health](https://onco.cc/institutions/palestinian-ministry-of-health/), [World Health Organization Cancer Programme](https://onco.cc/institutions/who/)

---
JSON: https://onco.cc/api/v1/entities/paper-bouquet-gaza-cancer-permits-survival-plos-one-2021.json